CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-19 | Taylor Ian Chief Scientific Officer | Exercise or conversion | +2,686 | 71,224 | ||
| 2020-03-19 | Taylor Ian Chief Scientific Officer | Sale | −826 | $37.61 | $31K | 70,398 |
| 2020-03-19 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −2,686 | 8,056 | ||
| 2020-03-19 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +4,791 | 153,906 | ||
| 2020-03-19 | Cassidy Sean A Chief Financial Officer | Sale | −1,514 | $37.61 | $57K | 152,392 |
| 2020-03-19 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −4,791 | 14,374 | ||
| 2020-03-18 | Margus Bradley Albert Director | Sale | −40,000 | $37.46 | $1.5M | 59,463 |
| 2020-03-18 | Margus Bradley Albert Director | Sale | −40,000 | $37.46 | $1.5M | 59,463 |
| 2020-02-27 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +235,000 | 235,000 | ||
| 2020-02-27 | Peck Ronald Chief Medical Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2020-02-27 | Cassidy Sean A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2020-02-27 | Taylor Ian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2020-02-07 | Cassidy Sean A Chief Financial Officer | Sale | −4,598 | $49.97 | $230K | 154,517 |
| 2020-02-07 | Cassidy Sean A Chief Financial Officer | Sale | −2,190 | $50.97 | $112K | 152,327 |
| 2020-02-07 | Cassidy Sean A Chief Financial Officer | Sale | −1,880 | $52.30 | $98K | 150,447 |
| 2020-02-07 | Cassidy Sean A Chief Financial Officer | Sale | −1,302 | $52.86 | $69K | 149,145 |
| 2020-02-07 | Cassidy Sean A Chief Financial Officer | Sale | −30 | $54.10 | $2K | 149,115 |
| 2020-01-28 | Taylor Ian Chief Scientific Officer | Exercise or conversion | +13,042 | $16.00 | $209K | 68,538 |
| 2020-01-28 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −1,300 | 1,300 | ||
| 2020-01-28 | Taylor Ian Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −11,742 | 11,648 |
Page 24 of 32 · 628 trades